Many researchers have found that CD4 + CD25+ regulatory T cells (Tregs) population increased in both the peripheral blood and tumor microenvironment in HCC patients, which correlates with a poor prognosis [2,3]. This evidence concerns the gene CD4 and hepatocellular carcinoma.